Solid Biosciences (NASDAQ:SLDB – Free Report) had its price objective boosted by Chardan Capital from $15.00 to $16.00 in a report published on Wednesday morning,Benzinga reports. The brokerage ...
Research analysts at Wedbush issued their FY2029 EPS estimates for shares of Arcus Biosciences in a note issued to investors ...
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech ...
Agco has a stable balance sheet with net/debt EBITDA of approximately 2.0 times and investment-grade credit ratings. The company has been formed via many acquisitions, and this continues as it pursues ...